文献速递生殖医学

发育第7天整倍体胚胎的生殖潜能如何

What is the reproductive potential of day 7 euploid embryos?
PubMed 文献 · Hum Reprod · 2019-01-01

该回顾性队列分析在单一学术体外受精中心2012年1月至2018年3月进行,对25775枚胚胎行滋养层活检及非整倍体植入前遗传学检测,并评估3824个单胚胎整倍体冻胚移植周期的临床结局。第7天活检胚胎整倍体率40.5%,显著低于第5天54.7%和第6天52.9%(P<0.0001);第7天整倍体胚胎移植仍可获得可接受的妊娠率和活产结局。

要点

  • 第7天活检胚胎整倍体率40.5%,显著低于第5天54.7%和第6天52.9%(P<0.0001)。
  • 校正年龄、抗苗勒管激素、BMI、胚胎质量和活检胚胎数后,第7天活检与非整倍体显著相关(对比第5天OR=1.34,95%CI 1.09-1.45,P=0.001;对比第6天OR=1.26,95%CI 1.07-1.16,P<0.001)。
  • 第7天整倍体单胚胎冻胚移植者植入、临床妊娠和活产 odds 显著降低,临床流产和多胎妊娠率无关联。

核心结论

  • 第7天整倍体胚胎移植可获得可接受的妊娠率和活产结局,但第7天活检胚胎整倍体率显著低于第5天和第6天。

研究设计与样本

  • 回顾性队列分析,在单一学术体外受精中心2012年1月至2018年3月进行,共25775枚胚胎行滋养层活检及非整倍体植入前遗传学检测,并评估3824个单胚胎整倍体冻胚移植周期。

主要发现

  • 第5天、第6天和第7天活检胚胎分别为12535枚、11939枚和1298枚。
  • 第7天囊胚整倍体率40.5%,显著低于第5天54.7%和第6天52.9%(P<0.0001)。
  • 校正年龄、抗苗勒管激素、BMI、胚胎质量和活检胚胎数后,第7天活检与非整倍体显著相关(对比第5天OR=1.34,95%CI 1.09-1.45,P=0.001;对比第6天OR=1.26,95%CI 1.07-1.16,P<0.001)。
  • 3824个单胚胎整倍体冻胚移植周期中,第5天2321周期、第6天1381周期、第7天116周期,各队列间植入率、临床妊娠率、活产率和临床流产率存在显著差异。
  • 使用第7天活检胚胎者植入、临床妊娠和活产的 odds 显著降低,临床流产和多胎妊娠率无关联。

临床怎么用

  • 作者认为,胚胎发育阶段、形态学分级和倍性状态是影响胚胎移植选择和植入潜能的关键因素。
  • 作者认为,第5天或第6天不符合滋养层活检标准的胚胎可能从延长培养至第7天中获益。
  • 作者表示,本研究显示对第5天或第6天未达活检标准的胚胎常规延长培养至第7天可使患者获益。

局限性

  • 研究的回顾性性质以及研究中心的实验室方案与其他生殖治疗中心可能存在差异,可能限制研究结果的外部有效性。
  • 因缺乏第5天或第6天对应胚胎而移植第7天活检整倍体胚胎的患者,可能引入选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the rate of euploidy and the reproductive potential of embryos biopsied after 6 days of development? SUMMARY ANSWER: Embryos biopsied after 6 days of development have higher rates of aneuploidy; however, day 7 euploid embryos selected at transfer can achieve acceptable pregnancy rates and live birth (LB) outcomes. WHAT IS KNOWN ALREADY: Recent publications have shown promising treatment results after euploid day 7 embryo transfers (ETs), albeit these studies were limited by small sample sizes. Whereas the current clinical standard has been to discard embryos that do not reach expansion by day 6 of development, the lack of robust data surrounding the clinical utility of day 7 embryos warrants further evaluation. STUDY DESIGN, SIZE, DURATION: Retrospective cohort analysis in a single, academic in vitro fertilization (IVF) center from January 2012 to March 2018. A total of 25 775 embryos underwent trophectoderm (TE) biopsy and preimplantation genetic testing for aneuploidy (PGT-A). Additionally, the clinical IVF outcomes of 3824 single, euploid frozen embryo transfer (FET) cycles were evaluated. PARTICIPANTS/MATERIALS, SETTING, METHODS: Cohorts were segregated by day of TE biopsy following oocyte retrieval (day 5, day 6 or day 7). PGT-A was performed to identify embryonic ploidy rates. Secondly, IVF and LB outcomes after single, euploid FET were evaluated for each cohort. MAIN RESULTS AND THE ROLE OF CHANCE: A total of day 5 (n = 12 535), day 6 (n = 11 939) and day 7 (n = 1298) embryos were included in the study analysis. The rate of embryo euploidy was significantly lower in day 7 blastocysts compared to day 5 or day 6 cohorts (day 7 = 40.5%; day 5 = 54.7%; day 6 = 52.9%; (P < 0.0001)). After adjusting for age, anti-Müllerian hormone, BMI, embryo quality and number of embryos biopsied, there was a significant association between aneuploidy and embryos biopsied on day 7 when compared to day 5 biopsied embryos (OR = 1.34, CI 95% 1.09-1.45, P = 0.001) and day 6 biopsied embryos (OR = 1.26, CI95% 1.07-1.16, P < 0.001).A sub-analysis of subsequent 3824 single, euploid FET cycles (day 5: n = 2321 cycles; day 6: n = 1381 cycles; and day 7: n = 116 cycles) showed significant differences among cohorts in implantation, clinical pregnancy, LB and clinical loss rates. There was a significant decrease in the odds of implantation, clinical pregnancy and LB, but no association with clinical loss or multiple pregnancy rates in patients who utilized day 7-biopsied embryos during treatment. LIMITATIONS, REASONS FOR CAUTION: The retrospective nature of the study and potential variability in the study center's laboratory protocol(s) compared to other reproductive treatment centers may limit the external validity of our findings. Additionally, patients who transferred euploid embryos, biopsied on day 7 of development due to an absence of day 5 or day 6 counterparts, may have introduced selection bias in this study. WIDER IMPLICATIONS OF THE FINDINGS: Embryonic developmental stage, morphological grade and ploidy status are paramount factors affecting ET selection and implantation potential. This study reveals that embryos ineligible for TE biopsy on day 5 or day 6 of development may benefit from extended culture to day 7. Our study demonstrates patient benefit when extended culture to day 7 of development is routinely performed for embryos failing to meet biopsy criteria by day 5 or 6. STUDY FUNDING/COMPETING INTEREST(S): No funding was received for the realization of this manuscript. Dr Alan Copperman is Advisor or Board Member of Sema 4 (Stake holder in Data), Progyny and Celmatix. TRIAL REGISTRATION NUMBER: This retrospective analysis was approved by an Institutional Review Board (WIRB PRO NUM: 20161791; Study Number: 1167398).

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Hernandez-Nieto C, Lee JA, Slifkin R, et al. What is the reproductive potential of day 7 euploid embryos? Hum Reprod. 2019. PMID: 31398251. doi:10.1093/humrep/dez129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。